Bremazocine

Bremazocine
Clinical data
Routes of; administration	Oral
ATC code	none;
Identifiers
	IUPAC name 6-ethyl- 3-[(1-hydroxycyclopropyl)methyl]- 11,11-dimethyl- 1,2,3,4,5,6-hexahydro- 2,6-methano- 3-benzazocin-8- ol; or; 2-(1-hydroxy- cyclopropylmethyl)- 5-ethyl- 9,9-dimethyl- 2'-hydroxy- 6,7-benzomorphan;
CAS Number	83829-76-9 ;
PubChem CID	1223;
IUPHAR/BPS	1603;
ChemSpider	1186;
UNII	ISF76M2DBE;
ChEMBL	ChEMBL1797687;
CompTox Dashboard (EPA)	DTXSID50868536 ;
Chemical and physical data
Formula	C20H29NO2
Molar mass	315.457 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC1(CC1)CN4[C@@H]3Cc2c(cc(O)cc2)[C@@](C3(C)C)(CC4)CC;

Bremazocine is a κ-opioid receptor agonist related to pentazocine. It has potent and long-lasting analgesic and diuretic effects. It has 200 times the activity of morphine, but appears to have no addictive properties and does not depress breathing. The crystal structure of bremazocine was determined in 1984

Clinical data

Routes of administration	Oral
ATC code	none
Identifiers
IUPAC name 6-ethyl- 3-[(1-hydroxycyclopropyl)methyl]- 11,11-dimethyl- 1,2,3,4,5,6-hexahydro- 2,6-methano- 3-benzazocin-8- ol or 2-(1-hydroxy- cyclopropylmethyl)- 5-ethyl- 9,9-dimethyl- 2'-hydroxy- 6,7-benzomorphan
CAS Number	83829-76-9^Y
PubChem CID	1223
IUPHAR/BPS	1603
ChemSpider	1186
UNII	ISF76M2DBE
ChEMBL	ChEMBL1797687
CompTox Dashboard (EPA)	DTXSID50868536
Chemical and physical data
Formula	C₂₀H₂₉NO₂
Molar mass	315.457 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES OC1(CC1)CN4[C@@H]3Cc2c(cc(O)cc2)[C@@](C3(C)C)(CC4)CC